| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c06bc0c2d1b16f9d16470b7e30874649 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K11-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2013-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdc4b6b88c8f99bd4c3b0b7ae618f2a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b335eb76311eb92740a8978c7b352ee5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67ca4068e0e1c14a87e16fc2dd961581
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8db4c0e8081dbfb68624dc5c80adfa56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1981e470eb2527d184176908cf6ece0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27df7f866eb58929a32fe68323ef9e51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5e28c7a1c10ade9f1fd1d88b22c8fc3 |
| publicationDate |
2015-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2847212-A1 |
| titleOfInvention |
Hexadepsipeptide analogues as anticancer compounds |
| abstract |
This invention relates to an isolated compound of Formula (1) or derivatives or pharmaceutically acceptable salts thereof. The invention also includes all isomeric and tautomeric forms of the compound of Formula (1) or the derivatives thereof. The present invention further relates to processes for the production of the compound of Formula (1) by fermentation of the fungal strain of Actinomycetes (PM0895172/MTCC 684), pharmaceutical compositions comprising the compound of Formula (1) as the active ingredient; and use of the said compounds or composition containing them in the treatment of cancer. |
| priorityDate |
2012-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |